Literature DB >> 21824358

Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.

S Nielsen1, C Frank, A Fruth, A Spode, R Prager, A Graff, A Plenge-Bönig, S Loos, M Lütgehetmann, M J Kemper, D E Müller-Wiefel, D Werber.   

Abstract

Infection with sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H- (sf STEC O157:H-) is rare, but emerging in Europe. The pathogen is typically isolated from paediatric patients with life-threatening haemolytic uraemic syndrome (HUS). It is unclear whether this observation primarily reflects the pathogen's virulence or its complex laboratory diagnosis, not routinely conducted in diarrhoeal patients. In summer 2009, four boys living in the same suburb in Germany developed diarrhoea-associated HUS: three were infected by sf STEC O157:H- and one died. We conducted two analytical epidemiological studies, an extensive search for diarrhoeal cases in potentially exposed groups, and an environmental investigation. Outbreak cases were residents of the suburb diagnosed with HUS, sf STEC O157:H- infection, or both between 24 July 2009 and 25 August 2009. Overall, we ascertained eight cases with a median age of 4 years (range: from 8 months to 9 years). Stool screening of 220 persons led to the identification of only four additional cases: two asymptomatic carriers and two diarrhoeal cases. HUS was strongly associated with visiting a local playground in July, particularly on 16th July (odds ratio = 42.7, P = 0.002). No other commonality, including food, was identified, and all environmental samples (n = 24) were negative. In this localized non-foodborne outbreak, the place of likely infection was a local playground. Sf STEC O157:H- infection apparently limits itself rarely to diarrhoeal illness and progresses frequently to HUS. Therefore, detection of and response to this hypervirulent pathogen primarily relies on HUS surveillance.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824358     DOI: 10.1111/j.1863-2378.2011.01405.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  7 in total

1.  Therapy: Azithromycin and decolonization after HUS.

Authors:  Michael E Seifert; Phillip I Tarr
Journal:  Nat Rev Nephrol       Date:  2012-05-01       Impact factor: 28.314

2.  Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:H- Isolates from Czech Patients with Novel Plasmid Composition Not Previously Seen in German Isolates.

Authors:  Andreas Bauwens; Monika Marejková; Barbara Middendorf-Bauchart; Rita Prager; Annelene Kossow; Wenlan Zhang; Helge Karch; Alexander Mellmann; Martina Bielaszewska
Journal:  Appl Environ Microbiol       Date:  2017-11-16       Impact factor: 4.792

3.  Point-of-care multiplex-PCR enables germ identification in haemolytic uremic syndrome 94 h earlier than stool culture.

Authors:  Luis Hernán Llano López; Pablo Melonari; Stephan Gehring; Daniel Schreiner; Sandra Grucci; Sofía Pérez Araujo; Lorena Di Pauli; Christina Oetzmann von Sochaczewski; Arne Schröder; Laura Piovano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-04       Impact factor: 3.267

4.  Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.

Authors:  A Kuehne; M Bouwknegt; A Havelaar; A Gilsdorf; P Hoyer; K Stark; D Werber
Journal:  Epidemiol Infect       Date:  2016-07-29       Impact factor: 4.434

Review 5.  Outbreaks of virulent diarrheagenic Escherichia coli--are we in control?

Authors:  Dirk Werber; Gérard Krause; Christina Frank; Angelika Fruth; Antje Flieger; Martin Mielke; Lars Schaade; Klaus Stark
Journal:  BMC Med       Date:  2012-02-02       Impact factor: 8.775

6.  Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017.

Authors:  Sabine Vygen-Bonnet; Bettina Rosner; Hendrik Wilking; Angelika Fruth; Rita Prager; Annelene Kossow; Christina Lang; Sandra Simon; Juliane Seidel; Mirko Faber; Anika Schielke; Kai Michaelis; Alexandra Holzer; Rolf Kamphausen; Daniela Kalhöfer; Sebastian Thole; Alexander Mellmann; Antje Flieger; Klaus Stark
Journal:  Euro Surveill       Date:  2017-05-25

7.  Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104.

Authors:  Karina Preußel; Michael Höhle; Klaus Stark; Dirk Werber
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.